Roche Holding AG (RHHBY) Stock: Rises After Strong Q3 Sales and Major FDA Approvals
TLDR Roche stock rises 1.18% as third-quarter sales climb 7% at constant exchange rates. Roche reports CHF 46.5 billion in nine-month sales, fueled by key medicines. FDA approvals for Tecentr






